ERP29P1

Across TCGA pan-cancer cohorts, ERP29P1 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of ERP29P1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where ERP29P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ERP29P1 is over-expressed in tumor, although a few such as PAAD and KIRC show the opposite, repressed pattern.

COAD, STAD, and HNSC are the cancer types where ERP29P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ERP29P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	+0.646	<.001	6	view →
STAD	All	II,III,IV	+0.306	.001	6	view →
HNSC	All	All	+0.119	.002	6	view →
LUSC	Male	All	+0.298	<.001	5	view →
BRCA	All	II,III,IV	+0.086	.030	4	view →
BLCA	Female	III,IV	+0.427	.007	3	view →
LIHC	All	All	+0.118	<.001	3	view →
CHOL	All	All	+0.457	.002	2	view →
PAAD	Female	All	−0.389	.016	2	view →
UCEC	All	All	+0.307	.035	2	view →
READ	Female	All	+0.277	.013	2	view →
KIRC	Male	II,III,IV	−0.108	.026	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

ERP29P1–COAD

Open the COAD breakdown →